Chronic Treatment with Fluoxetine Induces Sex-Dependent Analgesic Effects and Modulates HDAC2 and mGlu2 Expression in Female Mice

Chronic Treatment with Fluoxetine Induces Sex-Dependent Analgesic Effects and Modulates HDAC2 and mGlu2 Expression in Female Mice

Gender and sex differences in pain recognition and drug responses have been reported in clinical trials and experimental models of pain. Among antidepressants, contradictory results have been observed in patients treated with selective serotonin reuptake inhibitors (SSRIs). This study evaluated sex...

Full description

Bibliographic Details
Main Authors:	Magda Zammataro, Sara Merlo, Massimo Barresi, Carmela Parenti, Huijuan Hu, Maria A. Sortino, Santina Chiechio
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-10-01
Series:	Frontiers in Pharmacology
Subjects:	pain fluoxetine sex differences metabotropic glutamate 2 receptor HDAC2
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00743/full

Similar Items

The mGlu7 receptor provides protective effects against epileptogenesis and epileptic seizures
by: Benoit Girard, et al.
Published: (2019-09-01)

mGlu5 Receptor Functional Interactions and Addiction
by: Robyn eBrown, et al.
Published: (2012-05-01)

mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists
by: Copani Agata, et al.
Published: (2011-01-01)

mGlu2 mechanism-based interventions to treat alcohol relapse
by: Valentina Vengeliene, et al.
Published: (2022-09-01)

Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs
by: Paulina Cieślik, et al.
Published: (2018-09-01)

Expression of GABAAα1, GABAB1, and mGluR2 receptors in the lateral geniculate body of male neonates born to diabetic rats
by: Nasim Alipour, et al.
Published: (2023-07-01)

Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu<sub>5</sub> Receptors
by: Pawel Matulewicz, et al.
Published: (2022-11-01)

mGlu5 Receptor Blockade Within the Nucleus Accumbens Shell Reduces Behavioral Indices of Alcohol Withdrawal-Induced Anxiety in Mice
by: Kaziya M. Lee, et al.
Published: (2018-11-01)

Downregulation of surface AMPA receptor expression in the striatum following prolonged social isolation, a role of mGlu5 receptors
by: Li-Min Mao, et al.
Published: (2022-12-01)

Neuropeptide S-initiated sequential cascade mediated by OX1, NK1, mGlu5 and CB1 receptors: a pivotal role in stress-induced analgesia
by: Ming Tatt Lee, et al.
Published: (2020-01-01)

The role of mGlu4 receptors within the nucleus accumbens in acquisition and expression of morphine-induced conditioned place preference in male rats
by: Zahra Ebrahimi, et al.
Published: (2021-03-01)

Testing of analgesic effect of fluoxetine
by: Amra Begović, et al.
Published: (2004-11-01)

The effect of the mGlu8 receptor agonist, (S)-3,4-DCPG on acquisition and expression of morphine-induced conditioned place preference in male rats
by: Nazanin Kahvandi, et al.
Published: (2021-02-01)

Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice
by: Eileen Ruth S. Torres, et al.
Published: (2018-07-01)

mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits
by: James Maksymetz, et al.
Published: (2021-11-01)

Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis
by: Giuseppe Battaglia, et al.
Published: (2015-02-01)

Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172
by: Jessica Brown, et al.
Published: (2023-03-01)

Identification of the Candidate mGlu2 Allosteric Modulator THRX-195518 through In Silico Method and Evaluation of Its Neuroprotective Potential against Glutamate-Induced Neurotoxicity in SH-SY5Y Cell Line
by: Fadime Canbolat, et al.
Published: (2024-01-01)

Emergence of Endocytosis-Dependent mGlu1 LTD at Nucleus Accumbens Synapses After Withdrawal From Cocaine Self-Administration
by: Andrew F. Scheyer, et al.
Published: (2018-10-01)

Partial mGlu5 Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG
by: Kimberly M. Holter, et al.
Published: (2021-07-01)

Anti-mGluR1 encephalitis: Case illustration and systematic review
by: Osama Khojah, et al.
Published: (2023-04-01)

Group I metabotropic glutamate receptors (mGluR1/5) and neurodegenerative diseases
by: Elena I. Solntseva, et al.
Published: (2019-12-01)

Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications
by: Leyi Huang, et al.
Published: (2024-01-01)

Group I mGluRs in Therapy and Diagnosis of Parkinson’s Disease: Focus on mGluR5 Subtype
by: Shofiul Azam, et al.
Published: (2022-04-01)

Long-Term Depression of Striatal DA Release Induced by mGluRs via Sustained Hyperactivity of Local Cholinergic Interneurons
by: Nicola B. Mercuri, et al.
Published: (2021-12-01)

Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception
by: Crock Lara W, et al.
Published: (2012-03-01)

Role of Metabotropic Glutamate Receptors in Neurological Disorders
by: Rosalia Crupi, et al.
Published: (2019-02-01)

Metabotropic glutamate receptor 5 (mGluR5) regulates white adipocyte browning
by: LUO Xie, ZENG Li, YUAN Lei
Published: (2021-01-01)

Editorial: Emerging insights in glutamate receptor signaling in psychiatric, neurodevelopmental, and neurodegenerative diseases
by: Khaled S. Abd-Elrahman, et al.
Published: (2024-02-01)

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
by: Arthur Dechaumes, et al.
Published: (2021-02-01)

Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature
by: Kundian Guo, et al.
Published: (2023-03-01)

The regulatory role of NAAG-mGluR3 signaling on cortical synaptic plasticity after hypoxic ischemia
by: Kexin Li, et al.
Published: (2022-04-01)

Microglial Expression of Hdac1 and Hdac2 is Dispensable for Experimental Autoimmune Encephalomyelitis (EAE) Progression
by: Moumita Datta, et al.
Published: (2020-10-01)

Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic Pain
by: Serena Notartomaso, et al.
Published: (2022-06-01)

Dataset of eyeblink conditioning in mice treated with the selective mGluR1 antagonist JNJ16259685
by: Shoichi Tohyama, et al.
Published: (2023-04-01)

Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid
by: Carlos Guevara, et al.
Published: (2018-11-01)

Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury
by: Byrnes Kimberly R, et al.
Published: (2012-02-01)

Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
by: Falko Lange, et al.
Published: (2021-05-01)

Fluoxetine Overdose-Induced Seizure
by: Suchard, Jeffrey R
Published: (2008-08-01)

The Lateral Metalation of Isoxazolo[3,4-<i>d</i>]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors
by: Christina A. Gates, et al.
Published: (2023-09-01)